Does EVEROLIMUS Cause Injection site warmth? 33 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Injection site warmth have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 0.1% of all adverse event reports for EVEROLIMUS.
33
Reports of Injection site warmth with EVEROLIMUS
0.1%
of all EVEROLIMUS reports
2
Deaths
5
Hospitalizations
How Dangerous Is Injection site warmth From EVEROLIMUS?
Of the 33 reports, 2 (6.1%) resulted in death, 5 (15.2%) required hospitalization, and 1 (3.0%) were considered life-threatening.
Is Injection site warmth Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVEROLIMUS. However, 33 reports have been filed with the FAERS database.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Injection site warmth?
ETANERCEPT (4,011)
ADALIMUMAB (1,275)
DUPILUMAB (889)
ENBREL (544)
IXEKIZUMAB (480)
GLATIRAMER (372)
HYDROXYPROGESTERONE CAPROATE (287)
HUMIRA (261)
NALTREXONE (231)
TIRZEPATIDE (213)
Which EVEROLIMUS Alternatives Have Lower Injection site warmth Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE